Evidence map›Paper›PMID 31875939›Full record

ArticleClinical and experimental nephrology2020

Correction to: Preventive effect of early introduction of everolimus and reduced‑exposure tacrolimus on renal interstitial fibrosis in de novo living‑donor renal transplant recipients.

Hiroaki Ishida, Go Ogura, Saeko Uehara, Shinya Takiguchi, Yosuke Nakagawa, Naoto Hamano, Masahiro Koizumi, Takehiko Wada, Masafumi Fukagawa, Michio Nakamura

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Clinical and experimental nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Hiroaki IshidaDepartment of Transplant Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.
Go OguraDepartment of Pathology, Tokai University School of Medicine, Shimokasuya, Isehara, Japan.
Saeko UeharaDepartment of Transplant Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.
Shinya TakiguchiDepartment of Transplant Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.
Yosuke NakagawaDivision of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Shimokasuya, Isehara, Japan.
Naoto HamanoDivision of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Shimokasuya, Isehara, Japan.
Masahiro KoizumiDivision of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Shimokasuya, Isehara, Japan.
Takehiko WadaDivision of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Shimokasuya, Isehara, Japan.
Masafumi FukagawaDivision of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Shimokasuya, Isehara, Japan.
Michio NakamuraDepartment of Transplant Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan. mnakamura@tokai-u.jp.ORCID http://orcid.org/0000-0002-6606-1872
Tokai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the Original publication of the article, the co-author name has been misspelled as "Yousuke Nakagawa".

Identifiers

PMID31875939
OpenAlexW2991402544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.